Screening and cytological validation of cartilage degeneration-related genes in exosomes from osteoarthritis synovial fluid

doi:10.12307/2025.562

Abstract

Abstract: BACKGROUND: Exosomes have been confirmed to be closely related to cartilage degeneration in osteoarthritis. However, the role and mechanism of exosome-derived genes in cartilage degeneration of osteoarthritis have not been fully elucidated.
OBJECTIVE: Bioinformatics analyses were used to screen the genes related to cartilage degeneration in the synovial exosomes of patients with osteoarthritis, and to determine their biological functions and signaling pathways in order to provide new therapeutic targets for delaying cartilage degeneration in osteoarthritis.
METHODS: Firstly, osteoarthritis-related exosome dataset GSE185059 and cartilage degeneration dataset GSE114007 were downloaded from Gene Expression Omnibus (GEO) database to screen exosome-derived cartilage degeneration related genes. GO functional and KEGG pathway enrichment analyses were performed based on the screened exosome-derived cartilage degeneration related genes. Protein-protein interaction network was drawn and Ingenuity Pathway Analysis (IPA) was conducted to screen and obtain key exosome-derived cartilage degeneration-related genes. Finally, qRT-PCR was used to verify the expression of key genes in osteoarthritis cartilage tissue and interleukin-1β stimulated chondrocyte models.
RESULTS AND CONCLUSION: (1) There were 831 differentially expressed genes in the GSE185059 dataset and 5 323 differentially expressed genes in the GSE114007 dataset. A total of 94 exosome-derived cartilage degeneration related genes were screened after the intersection of these differentially expressed genes, of which 51 genes were down-regulated and 43 genes were up-regulated. (2) GO functional enrichment analysis showed that the up-regulated genes were mainly involved in the positive regulation of cell-cell adhesion, the positive regulation of T cell activation, and chronic inflammatory response, while the down-regulated genes were mainly involved in biological processes such as cell aggregation, cartilage differentiation and development, and skeletal system morphogenesis. (3) KEGG pathway enrichment analysis showed that exosome-derived cartilage degeneration-related genes were mainly involved in tryptophan enrichment metabolism, vitamin B6 metabolism, and leukocyte transendothelial migration. (4) The constructed protein-protein interaction network confirmed the existence of multiple interaction relationships among exosome-derived cartilage degeneration-related genes. Combined with five algorithms in CytoHubba software, four key exosome-derived cartilage degeneration-related genes were further screened, namely THY1, CYP1A1, NFKB2, and COL6A3. (5) The results of qRT-PCR showed that compared with normal cartilage, the expressions of THY1 and COL6A3 in osteoarthritic cartilage were increased, while the expression of CYP1A1 and NFKB2 was decreased. Similarly, compared with the unstimulated group, the expression of THY1 and COL6A3 in the interleukin-1β induced chondrocytes was upregulated, while the expression of CYP1A1 and NFKB2 was downregulated. (6) These results indicate that THY1, CYP1A1, NFKB2, and COL6A3 are genes related to cartilage degeneration in the exosomes of synovial fluid of patients with osteoarthritis, and may participate in the pathogenesis of osteoarthritis by regulating biological processes such as protein tyrosine kinase activity and lipid metabolism, as well as nuclear factor-κB signaling pathway and focal adhesion signaling pathway. However, the specific regulatory roles and molecular mechanisms of these key genes in cartilage degeneration need to be further verified by experiments.

Key words: ">osteoarthritis, synovial fluid, exosome, cartilage degeneration, bioinformatics analysis, cytological verification, chondrocyte, gene expression, engineered exosomes

CLC Number:

Ma Weibang, Xu Zhe, Yu Qiao, Ouyang Dong, Zhang Ruguo, Luo Wei, Xie Yangjiang, Liu Chen. Screening and cytological validation of cartilage degeneration-related genes in exosomes from osteoarthritis synovial fluid[J]. Chinese Journal of Tissue Engineering Research, 2025, 29(36): 7783-7789.

Figures/Tables 2

References

[1] MINNIG MCC, GOLIGHTLY YM, NELSON AE. Epidemiology of osteoarthritis: literature update 2022-2023. Curr Opin Rheumatol. 2024;36(2):108-112.
[2] 张烽,王斌,曹蔼萱,等.原发性膝关节骨关节炎严重程度的危险因素分析[J].中华创伤骨科杂志,2024,26(8):698-704.
[3] FUJII Y, LIU L, YAGASAKI L, et al. Cartilage Homeostasis and Osteoarthritis. Int J Mol Sci. 2022;23(11):6316.
[4] 章晓云,曾浩,孟林.膝骨关节炎疼痛机制及治疗研究进展[J].中国疼痛医学杂志,2023,29(1):50-58.
[5] 张琪,于湄,刘磊,等.工程化外泌体研究现状与临床转化的挑战[J].中国组织工程研究,2023,27(19):3052-3060.
[6] HE C, ZHENG S, LUO Y, et al. Exosome Theranostics: Biology and Translational Medicine. Theranostics. 2018;8(1):237-255.
[7] NI Z, KUANG L, CHEN H, et al. The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis. Cell Death Dis. 2019;10(7):522.
[8] LI Z, WANG Y, XIANG S, et al. Chondrocytes-derived exosomal miR-8485 regulated the Wnt/β-catenin pathways to promote chondrogenic differentiation of BMSCs. Biochem Biophys Res Commun. 2020;523(2):506-513.
[9] JI Y, XIONG L, ZHANG G, et al. Synovial fluid exosome-derived miR-182-5p alleviates osteoarthritis by downregulating TNFAIP8 and promoting autophagy through LC3 signaling. Int Immunopharmacol. 2023; 125(Pt A):111177.
[10] LAI C, LIAO B, PENG S, et al. Synovial fibroblast-miR-214-3p-derived exosomes inhibit inflammation and degeneration of cartilage tissues of osteoarthritis rats. Mol Cell Biochem. 2023;478(3):637-649.
[11] 中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[12] LIU Q, HAN M, WU Z, et al. DDX5 inhibits hyaline cartilage fibrosis and degradation in osteoarthritis via alternative splicing and G-quadruplex unwinding. Nat Aging. 2024;4(5):664-680.
[13] MCCLURG O, TINSON R, TROEBERG L. Targeting Cartilage Degradation in Osteoarthritis. Pharmaceuticals (Basel). 2021;14(2):126.
[14] CHEN A, CHEN Y, RONG X, et al. The application of exosomes in the early diagnosis and treatment of osteoarthritis. Front Pharmacol. 2023; 14:1154135.
[15] 王刘欣,王贺林,张勉.外泌体在骨关节炎发病及治疗中的作用和机制研究[J].中国现代医学杂志,2022,32(18):63-69.
[16] QIAN Y, CHU G, ZHANG L, et al. M2 macrophage-derived exosomal miR-26b-5p regulates macrophage polarization and chondrocyte hypertrophy by targeting TLR3 and COL10A1 to alleviate osteoarthritis. J Nanobiotechnology. 2024;22(1):72.
[17] XU J, ZHOU K, GU H, et al. Exosome miR-4738-3p-mediated regulation of COL1A2 through the NF-κB and inflammation signaling pathway alleviates osteoarthritis low-grade inflammation symptoms. Biomol Biomed. 2024;24(3):520-536.
[18] QIU M, XIE Y, TAN G, et al. Synovial mesenchymal stem cell-derived exosomal miR-485-3p relieves cartilage damage in osteoarthritis by targeting the NRP1-mediated PI3K/Akt pathway: Exosomal miR-485-3p relieves cartilage damage. Heliyon. 2024;10(2):e24042.
[19] LIU Y, LU T, LIU Z, et al. Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis. Front Immunol. 2022;13:936606.
[20] 袁长深,廖书宁,李哲,等.N6-甲基腺苷相关调节因子与骨关节炎：生物信息学和实验验证分析[J].中国组织工程研究,2024,28(11): 1724-1729.
[21] LUO D, GAO X, ZHU X, et al. Biomarker screening using integrated bioinformatics for the development of “normal-impaired glucose intolerance-type 2 diabetes mellitus”. Sci Rep. 2024;14(1):4558.
[22] WU X, BIAN B, LIN Z, et al. Identification of exosomal mRNA, lncRNA and circRNA signatures in an osteoarthritis synovial fluid-exosomal study. Exp Cell Res. 2022;410(1):112881.
[23] CHEN P, RUAN A, ZHOU J, et al. Identification and analysis of key microRNAs derived from osteoarthritis synovial fluid exosomes. Chin Med J (Engl). 2023;136(2):245-247.
[24] YI C, ZANG N, GAO L, et al. THY1 is a prognostic-related biomarker via mediating immune infiltration in lung squamous cell carcinoma (LUSC). Aging (Albany NY). 2024;16(11):9498-9517.
[25] PAINE A, WOELLER CF, ZHANG H, et al. Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice. FASEB J. 2018;32(6):3174-3183.
[26] GUO HL, CHEN G, SONG ZL, et al. COL6A3 promotes cellular malignancy of osteosarcoma by activating the PI3K/AKT pathway. Rev Assoc Med Bras (1992). 2020;66(6):740-745.
[27] WANG K, PENG X, ZHANG R, et al. COL6A3 enhances the osteogenic differentiation potential of BMSCs by promoting mitophagy in the osteoporotic microenvironment. Mol Biol Rep. 2024;51(1):206.
[28] WINSLOW S, SCHOLZ A, RAPPL P, et al. Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation. PLoS One. 2019;14(1):e0209694.
[29] WANG X, WU H, ZHANG Q, et al. NFKB2 inhibits NRG1 transcription to affect nucleus pulposus cell degeneration and inﬂammation in intervertebral disc degeneration. Mech Ageing Dev. 2021;197:111511.
[30] WEI Y, LUO L, GUI T, et al. Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci Transl Med. 2021;13(576):eabb3946.
[31] LI K, ZHANG Y, ZHANG Y, et al. Tyrosine kinase Fyn promotes osteoarthritis by activating the β-catenin pathway. Ann Rheum Dis. 2018;77(6):935-943.
[32] FELSON DT, MISRA D, LAVALLEY M, et al. MOST Study Investigators. Essential Fatty Acids and Osteoarthritis. Arthritis Care Res (Hoboken). 2024;76(6):796-801.
[33] LIU J, JIA S, YANG Y, et al. Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K/Akt/NF-κB and NLRP3/caspase-1/GSDMD signaling. Biomed Pharmacother. 2023;158:114118.
[34] BAN Y, WANG Y, QIAO L, et al. Total lignans from Vitex negundo seeds attenuate osteoarthritis and their main component vitedoin A alleviates osteoclast differentiation by suppressing ERK/NFATc1 signaling. Phytother Res. 2023;37(4):1422-1434.
[35] HUANG Y, LIAO J, VLASHI R, et al. Focal adhesion kinase (FAK): its structure, characteristics, and signaling in skeletal system. Cell Signal. 2023;111:110852.